147 related articles for article (PubMed ID: 25213062)
1. Successful desensitization protocol for delayed cutaneous eruption to temozolomide.
Clayton E; Madamba J; Kong XT; Braskett M
J Allergy Clin Immunol Pract; 2014; 2(5):626-8. PubMed ID: 25213062
[No Abstract] [Full Text] [Related]
2. Rapid desensitization with temozolomide in patients with delayed maculopapular rash.
Alonso-Llamazares A; Vega-Castro A; Beitia-Mazuecos JM; Mateo-Borrega B; Cardenas-Contreras R
J Investig Allergol Clin Immunol; 2012; 22(6):448-9. PubMed ID: 23101195
[No Abstract] [Full Text] [Related]
3. Hypersensitivity to chemotherapeutics: a cross sectional study with 35 desensitisations.
Goksel O; Goksel T; Cok G; Karakus H; Bacakoglu F; Goker E; Uslu R; Erdinc M
Int J Clin Oncol; 2015 Apr; 20(2):395-404. PubMed ID: 25056643
[TBL] [Abstract][Full Text] [Related]
4. Successful rapid desensitization to temozolomide: A case series.
Divekar R; Butterfield J; Maddox D
J Allergy Clin Immunol Pract; 2016; 4(3):545-6. PubMed ID: 26868726
[No Abstract] [Full Text] [Related]
5. Successful Bendamustine Desensitization for a Delayed-Type Hypersensitivity Reaction.
Martin Garcia C; Sierra Pacho M; Moreno Rodilla E; Callejo Melgosa AM; Martinez Alonso JC; Fernández Colino T; Acevedo Del Barrio G; Gil Valiño C; Eiris Aradas MC
J Investig Allergol Clin Immunol; 2019 Feb; 29(1):68-69. PubMed ID: 30785109
[No Abstract] [Full Text] [Related]
6. Systemic delayed hypersensitivity reaction to chlorambucil: a case report and literature review.
Bianchi L; Hansel K; Pelliccia S; Tramontana M; Stingeni L
Contact Dermatitis; 2018 Feb; 78(2):171-173. PubMed ID: 29341183
[No Abstract] [Full Text] [Related]
7. Successful treatment of palmar-plantar erythrodysesthesia possibly due to temozolomide with dexamethasone.
Kanat O; Baskan BE; Kurt E; Evrensel T
J Postgrad Med; 2007; 53(2):146. PubMed ID: 17495388
[No Abstract] [Full Text] [Related]
8. [Induction of allergic phenomena by insulin preparations].
Wenig KH; Calap J
Munch Med Wochenschr; 1971 Mar; 113(10):345-52. PubMed ID: 4396155
[No Abstract] [Full Text] [Related]
9. Successful Capecitabine Desensitization for a Delayed-Type Hypersensitivity Reaction.
Demir S; Olgac M; Saglam S; Gelincik A; Colakoglu B; Buyukozturk S
J Investig Allergol Clin Immunol; 2016; 26(1):66-7. PubMed ID: 27012024
[No Abstract] [Full Text] [Related]
10. Urticarial hypersensitivity reaction caused by temozolomide.
Pothiawala S; Hsu MY; Yang C; Kesari S; Ibrahimi OA
J Drugs Dermatol; 2010 Sep; 9(9):1142-4. PubMed ID: 20865848
[TBL] [Abstract][Full Text] [Related]
11. In vitro cytokine production after in vivo desensitization in an allopurinol-induced delayed allergic reaction.
Martínez-Aranguren R; Gamboa PM; García-Lirio E; Alonso A; Sanz ML
Ann Allergy Asthma Immunol; 2012 Apr; 108(4):280-1. PubMed ID: 22469450
[No Abstract] [Full Text] [Related]
12. [Toxicodermia by bendamustine: development of a desensization protocol].
Sangrador Pelluz C; Luis Hidalgo MM; Martínez García M; Pérez-Serrano Lainosa MD; Soler Company E
Farm Hosp; 2013; 37(5):421-3. PubMed ID: 24128107
[No Abstract] [Full Text] [Related]
13. Celecoxib desensitization: continued temozolomide/celecoxib chemotherapy after a celecoxib-induced hypersensitivity reaction.
Burbach GJ; Vajkoczy P; Zuberbier T
Anticancer Drugs; 2012 Nov; 23(10):1118-20. PubMed ID: 23026982
[TBL] [Abstract][Full Text] [Related]
14. Immediate and Delayed Hypersensitivity Reactions to Proton Pump Inhibitors: Evaluation and Management.
Otani IM; Banerji A
Curr Allergy Asthma Rep; 2016 Mar; 16(3):17. PubMed ID: 26810177
[TBL] [Abstract][Full Text] [Related]
15. Slow lenalidomide desensitization protocol for patients with multiple myeloma: case series from a single center.
Yau P; Jimenez-Zepeda VH; Bailey K; Duggan P; Tay J; Bahlis NJ; Neri P; McCulloch S
Leuk Lymphoma; 2019 Dec; 60(13):3199-3203. PubMed ID: 31190585
[TBL] [Abstract][Full Text] [Related]
16. Management of immediate hypersensitivity reaction to glatiramer acetate.
Amsler E; Autegarden JE; Gaouar H; Frances C; Soria A
Eur J Dermatol; 2017 Feb; 27(1):92-95. PubMed ID: 27799134
[No Abstract] [Full Text] [Related]
17. [Cutaneous reactions to heparin: immunological and clinical aspects].
Mathelier-Fusade P; Deschamps A; Abuaf N; Leynadier F
Presse Med; 1995 Feb; 24(6):323-5. PubMed ID: 7899395
[TBL] [Abstract][Full Text] [Related]
18. [Not Available].
CEDEF
Ann Dermatol Venereol; 2018 Mar; 145 Suppl 1():S189-S200. PubMed ID: 29428446
[No Abstract] [Full Text] [Related]
19. Delayed-type hypersensitivity to protamine as a complication of insulin therapy.
Raap U; Liekenbröcker T; Kapp A; Wedi B
Contact Dermatitis; 2005 Jul; 53(1):57-8. PubMed ID: 15982236
[No Abstract] [Full Text] [Related]
20. Temozolomide-induced desquamative skin rash in a patient with metastatic melanoma.
Pick AM; Neff WJ; Nystrom KK
Pharmacotherapy; 2008 Mar; 28(3):406-9. PubMed ID: 18294121
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
